1Ikeda Y, Takagi A, Nakata Y, et al. A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipo- protein lipase deficiency[ J]. Clin Chim Acta,2002,316(1) : 179-185.
2Frits H, Femke DB, Amoud VDL, et al. The hypolipidemic action of bezafi Bratet therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase : no effects on VLDL substrate affinity to lipolysis or LDL receptor binding[ J]. Atherosclerosis, 2000, 153(2) : 363-371.
4Ukkola O, Tremblay A, Bouchard C. Lipoprotein lipase polymorphisms and responses to long-term overfeeding[ J]. J Int Med,2002,251 (5):429-436.
5Pasalic D, Sertic J, Kunovic B, et al. Lipoprotein lipase gene polymorphism and lipid profile in patients with hyper-triglyceridemia[ J]. Croat Med J,2001,42(5) :517-522.
6Ascaso JF, Real JT, Merchante A, et al. Lipoprotein phenotype and insulin resistance in familial combined hyperllpidemia [ J]. Metabolism,2000,49(12) : 1627-1631.
7Picard F, Boivin A, Lalonde J, et al. Resistance of adipose tissue lipoprotein lipase to insulin action in rat fed an obesity-promoting diet[J] .Am J Physiol Endocrinol Metab,2002,282(2):E412-418.
8Panarotto D, Remillard P, Bouffard L, et al. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner[ J] .Eur J Clin Invest,2002,32(2) :84-92.
9Hitsumoto T, Ohsawa H, Uchi T, et al. Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis[J]. Atherosclerosis, 2000,153 (2) : 391-396.
10Totsuka M, Miyashita Y, Ito Y, et al. Enhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration[ J]. Atherosclerosis,2000,153(1) : 175-179.
6ELLEGARD L, BOSAEUS I, ANDERSON H. Will recommended changes in fat and fiber intake affect cholesterol absorption and sterol excretion : an ileostomy study[ J]. Eur J Clin Nutr, 2000, 54 (4) : 306-313.
7IKEDA Y,TAKAGI A,NAKATA Y, et al. A family-based study of hyperinsu linemia and hypertriglyceridemia in heterozygous lipo protein lipase deficiency[ J]. Clin Chim Acta,2002,316 ( 1 ) : 179.
8SAMPATH H, SC B, NIAMBI J M. Ployunsaturated fatty acid regulation of gene expression [J]. Nutr Rev,2004,62:333-339.
9BERGER J P, AKIVAMA T E,MEINKE P T. PPARs: the rapeutic targets for metabolic disease [ J]. Trends Pharmacol Sci ,2005,26 (5) : 244-251.
10MCMAHON G T, PLUTZKY J, DAHER E, et al. Effect of a peroxisome proliferators-activated receptor-γ agonist on myocardial blood flow in type 2 diabetes [ J ]. Diabetes Care,2005,28 ( 5 ) : 1145- 1150.
